Pasithea Therapeutics (KTTA) Current Assets (2020 - 2026)

Pasithea Therapeutics' Current Assets history runs 7 years deep, the most recent figure standing at $52.7 million for Q1 2026.

• In Q1 2026, Current Assets rose 760.93% year-over-year to $52.7 million; the TTM figure through Mar 2026 stood at $52.7 million (up 760.93% YoY), while the FY2025 annual figure was $56.5 million, up 666.24% from the prior year.
• Current Assets came in at $52.7 million for Q1 2026 at Pasithea Therapeutics, down from $56.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $56.5 million in Q4 2025 to a low of $5.5 million in Q3 2025.
• A 5-year average of $26.1 million and a median of $20.8 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slumped 69.17% in 2024 and soared 760.93% in 2026, its largest moves.
• Pasithea Therapeutics' Current Assets stood at $34.1 million in 2022, then tumbled by 51.02% to $16.7 million in 2023, then tumbled by 55.86% to $7.4 million in 2024, then surged by 666.24% to $56.5 million in 2025, then slipped by 6.6% to $52.7 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $52.7 million, $56.5 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison